Previous studies have also reported that RCN1 is highly expressed in lung cancer [12], liver cancer [10], laryngeal carcinoma [24], renal cell carcinoma [25], and prostate cancer [13], which is consistent with our research findings. Here, RCN1 is linked to prostate carcinoma.